<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-HP9YQEQ4</identifier><date>2020</date><creator>Rožman, Samo</creator><relation>documents/doc/H/URN_NBN_SI_doc-HP9YQEQ4_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-HP9YQEQ4_001.txt</relation><format format_type="issue">3</format><format format_type="volume">71</format><format format_type="type">article</format><format format_type="extent">str. 230-236</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">35592707</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-HP9YQEQ4</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">chemotherapy</subject><subject language_type_id="eng">colitis</subject><subject language_type_id="slv">diareja</subject><subject language_type_id="eng">diarrhoea</subject><subject language_type_id="eng">immunotherapy</subject><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">kolitis</subject><title>S protitumornimi zdravili povzročena diareja</title><title>Systemic cancer treatment-related diarrhoea</title></Record>